News Conference News STS 2024 Where You Live Matters More Than Hospital Volume for Heart Transplant Outcomes Yael L. Maxwell February 06, 2024
News Conference News STS 2024 SAVR After Failed TAVI on the Rise, With High Mortality Yael L. Maxwell February 05, 2024
News Conference News ISET 2024 AI Tools to Meet Every Need? The Future of Vascular Medicine Caitlin E. Cox February 02, 2024
News Conference News ISET 2024 Will IVUS Ever Take Off in Peripheral Vascular Interventions? Caitlin E. Cox January 31, 2024
News Conference News ISET 2024 AI in Pulmonary Embolism: ‘Transformative’ for Patient Care Caitlin E. Cox January 30, 2024
News Conference News STS 2024 STS Survey Identifies Stark Gender Disparities in Compensation Yael L. Maxwell January 30, 2024
News Conference News ISET 2024 Venous Stents: How to Choose Among the Wealth of Options Caitlin E. Cox January 26, 2024
News Conference News ISET 2024 How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy Caitlin E. Cox January 24, 2024
News Conference News ISET 2024 AI Tools Can Flourish in CV Medicine, but Clinical Acumen Remains Key Caitlin E. Cox January 23, 2024
News Conference News AHA 2023 For LGBTQ+ Patients With Heart Failure, EMR Details Often Absent Caitlin E. Cox November 17, 2023
News Conference News AHA 2023 ‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE Yael L. Maxwell November 17, 2023
News Conference News AHA 2023 Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation L.A. McKeown November 17, 2023
News Conference News AHA 2023 AI Improves Detection of Cardiomyopathy in Pregnancy L.A. McKeown November 15, 2023
News Conference News AHA 2023 New CVD Risk Tool Can Spur Even Earlier Talk About Prevention Yael L. Maxwell November 14, 2023
News Conference News AHA 2023 Automatic Scripts, Pharmacist Phone Calls Boost Statin Prescribing Shelley Wood November 14, 2023
News Conference News AHA 2023 Seeing Sticker Price for HFrEF Meds Opens Door to Discussions Caitlin E. Cox November 14, 2023
News Conference News AHA 2023 Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study Michael O'Riordan November 13, 2023
News Conference News AHA 2023 New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference? Shelley Wood November 13, 2023
News Conference News AHA 2023 Intensive BP Reduction Lowers Dementia Risk in China Rural Hypertension Study Todd Neale November 12, 2023
News Conference News AHA 2023 RNA-Interference Agent Zilebesiran Looks Promising for BP: KARDIA-1 Caitlin E. Cox November 11, 2023